Patents for A61P 23 - Anaesthetics (4,141)
06/2002
06/11/2002US6403589 Nucleoside transport inhibitor
06/06/2002WO2001094414A3 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE
06/05/2002EP1210040A2 Apparatus and method for anesthetizing the cervical region of a female
06/04/2002USRE37729 Useful as antipsychotic and analgesic agents.
06/04/2002US6399087 Dissolving in a solvent, emulsification with water and surfactant
05/2002
05/30/2002WO2001072714A3 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
05/30/2002WO2001050994A8 Topical medicated bioadhesive compositions and methods of use and preparation thereof
05/28/2002US6395291 Use for pain management
05/23/2002WO2002040005A2 Blockade of sodium channels by phenol derivatives
05/23/2002WO2001049651A3 Aminomethyl-phenyl-cyclohexanone derivatives
05/23/2002US20020061886 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
05/22/2002EP1206934A1 Blockade of sodium channels by phenol derivatives
05/21/2002US6391832 Medical emulsion for lubrication and delivery of drugs
05/16/2002WO2002038145A1 Compositions and methods for sedating, anaesthetising and euthanasing aquatic organisms
05/16/2002WO2001049654A3 Substituted aminomethyl-phenyl-cyclohexane derivatives
05/14/2002US6387392 Comprising a pressure-sensitive adhesive layer containing a drug on a cloth which prevents the dilution of drug by saliva
05/10/2002WO2001038326A3 Imidazo-pyridine derivatives as ligands for gaba receptors
05/09/2002US20020054915 Prolonged anesthesia in joints and body spaces
05/08/2002EP1203072A2 Personal care articles
05/08/2002EP1202719A1 Anesthetic composition for intravenous injection comprising propofol
05/08/2002CN1348363A Novel pharmaceutical salt form
05/02/2002US20020052319 Topical anesthetic/opioid formulations and uses thereof
05/02/2002US20020051753 Comprising a pressure-sensitive adhesive layer containing a drug on a cloth which prevents the dilution of drug by saliva
05/02/2002EP1201241A2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic
05/02/2002EP1200057A1 Colloidal composition for esthetic correction
05/02/2002DE10049481A1 Substituierte C-Cyclohexylmethylamin-Derivate C-substituted derivatives cyclohexylmethylamine
05/01/2002CN1347308A Skin care compositions contg. combination of skin care actives
04/2002
04/25/2002WO2002032880A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
04/25/2002US20020049212 Benzimidazole compounds and salts containing piperidine ring are useful in treatment or prevention or medical conditions selected from pain, and inflammatoy diseases; analgesics
04/25/2002CA2426097A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
04/24/2002EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
04/24/2002CN1346278A Regulation of anaesthesia
04/24/2002CN1083431C Novel heterocyclic compounds
04/18/2002WO2002030870A2 Substituted c-cyclohexylmethylamine derivatives
04/18/2002US20020045662 Stable gabapentin having pH within a controlled range
04/18/2002US20020045229 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans
04/18/2002CA2423935A1 Substituted c-cyclohexylmethylamine derivatives
04/17/2002EP0706395B1 Use of ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motor blockade
04/11/2002WO2001060844A3 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system
04/10/2002EP1194410A1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds
04/10/2002CN1344155A Transnasal transport/immunisation with highly adaptable carriers
04/10/2002CN1343491A Method for localized anesthesia and analgesia
04/04/2002WO2002026958A2 Human neprilysin protease
04/04/2002WO2002026724A1 Cyclized benzamide neurokinin antagonists for use in therapy
04/04/2002US20020040025 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
04/04/2002DE10045829A1 Volatile Anästhesiemittel mit Xenon Volatile anesthetic xenon
04/02/2002US6365664 Gels formed by the interaction of poly(aldehyde) with various substances
03/2002
03/28/2002WO2002024715A2 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
03/28/2002WO2002024181A2 The use of melatonin for induction of general anesthesia
03/28/2002WO2001072279A3 Medical emulsion for lubrication and delivery of drugs
03/28/2002CA2423095A1 The use of melatonin for induction of general anesthesia
03/27/2002EP1189602A1 Morphine sulphate microgranules, method for preparing same and compositions containing same
03/27/2002EP1189597A1 Oil-core compositions for the sustained release of hydrophobic drugs
03/27/2002EP0858445B1 New [(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics
03/21/2002WO2002022129A1 A method of analgesia
03/21/2002WO2002022128A1 A method of local anesthesia and analgesia
03/21/2002WO2002022116A1 Volatile anaesthetic with xenon
03/21/2002WO2001076599B1 Process of making racemic bupivacaine's enantiomers, levobupivacaine's pharmaceutical compositions, levobupivacaine's pharmaceutical compositions formulated on its free base form or its pharmaceutical acceptable salts and use of levobupivacaine's pharmaceutical compositions formulated on its free base form
03/21/2002US20020035141 Use of melatonin for induction of general anesthesia
03/21/2002US20020033174 Inhalable aerosol medicament for the treatment or prevention of pain
03/20/2002EP1187916A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
03/20/2002EP1187635A1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist
03/20/2002EP0957906B1 Local anesthetic for external use
03/19/2002US6358706 Nucleotide sequences coding membrane protein; for use in treatment of epilepsy, schizophrenia, depression, sleep, stress, muscle, endocrine, respiratory, fertility, contraceptive, cardiovascular disorders and atherosclerosis
03/19/2002CA2078885C Pharmaceutical compositions containing amethocaine
03/14/2002WO2001068612A3 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
03/13/2002EP1185286A1 Mu o-conopeptides and their use as local anesthetics
03/13/2002EP1185267A1 Dermal anesthetic agents
03/13/2002EP1185171A1 Compositions and methods comprising morphine gluconate
03/13/2002CN1339955A Gels formed by the interaction of poly(aldehyde) with various sabstances
03/12/2002US6355637 Local anesthetic compounds
03/07/2002WO2002018386A1 2-PYRIDINYL-6,7,8,9-TETRAHYDROPYRIMIDO[1,2-a]PYRIMIDIN-4-ONE AND 7-PYRIDINYL-2,3-DIHYDROIMIDAZO[1,2-a]PYRIMIDIN-5(1H)ONE DERIVATI VES
03/07/2002WO2002017881A2 Transdermal pharmaceutical delivery composition
03/07/2002WO2001089474A3 O/w emulsion
03/07/2002WO2001064187B1 Anaesthetic formulations
03/07/2002WO2001028591A3 Injection vehicle for polymer-based formulations
03/06/2002EP1183011A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto
03/06/2002CN1338923A Method for controlling liposome size
02/2002
02/27/2002EP1181931A2 Intraoral adhesive preparation
02/27/2002CN1337877A Method of preparing stable suspension of insoluble microparticles
02/26/2002US6350465 Inserting nozzle on priming device into nasal cavity of patient, discharging priming anesthetic, inserting nozzle on pain medication delivery device to point proximate sphenopalatine ganglion, discharging primary anesthetic
02/26/2002CA2128119C Benzospiroalkene derivatives, process for their preparation and pharmaceutical compositions containing them
02/21/2002WO2001043775A3 Hydroxide-releasing agents as skin permeation enhancers
02/21/2002US20020022667 For inducing or maintaining anesthesia or sedation in a patient
02/21/2002US20020020462 Process and plant for the dynamic packaging of gases, especially those for medical use
02/21/2002DE10035865A1 Treatment or prophylaxis of migraine, by intranasal administration of aqueous spray solution of local anesthetic, preferably lidocaine hydrochloride
02/20/2002EP1180053A1 Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy
02/20/2002EP1180014A2 Injectable anesthetic formulation
02/14/2002WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses
02/14/2002US20020019383 3-amido or 3-sulfonylamino azetidine compounds and their preparation; high affinity for cannabinoid receptor CB1 type, useful in treating central nervous system, immune, gastrointestinal or cardiovascular disorders, drug abuse
02/07/2002US20020016464 Sodium channel blockers used to treat amyotrophic lateral sclerosis; analgesics, anticonvulsants, antidepressants, local anesthetics and antiarrhythmics
02/07/2002US20020016373 Adding to the fluoroether compound selected from evoflurane, enflurane, isoflurane, methoxyflurane and desflurane an effective stabilizing amount of a lewis acid inhibitor to prevent the degradation of fluoroether
02/07/2002US20020016338 Levobupivacaine and its use
02/06/2002EP1177793A1 Inhalable medicinal aerosol composition for pain treatment or prevention
02/06/2002EP1177206A1 3alpha-hydroxy-3beta methoxymethyl-21-heterocycle substituted steroids with anaesthetic activity
02/06/2002EP1176967A1 Management of pain after joint surgery
02/06/2002EP1176933A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof
02/06/2002CN1334809A Nonsteroidal antiinflammatories
02/03/2002CA2353364A1 Aerosol for the treatment or prevention of pain
01/2002
01/31/2002WO2002007743A2 Piper methysticum plant extract
1 ... 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 ... 42